Bildkälla: Stockfoto

Saniona: Our View on Updated Timelines - Redeye

Redeye doesn't reckon today's news as overly dramatic, although it is unfortunate that the trials with tesomet won't start in this half of 2021.

Redeye doesn't reckon today's news as overly dramatic, although it is unfortunate that the trials with tesomet won't start in this half of 2021.
Börsvärldens nyhetsbrev
ANNONSER